Protective effects of a novel RIPK3 antagonist against neutrophil necroptosis and formation of neutrophil extracellular traps

Authors

Koren, E., Foehr, E., Faruqi, T., Gardiner, E., Mahadevan, R.

Abstract

Functionally competent, highly purified neutrophils were isolated from healthy human donors. Neutrophil necroptosis and neutrophil extracellular trap (NET) formation were induced using TNF-a in combination with the pan-caspase inhibitor zVAD-FMK and the IAP antagonist BV6. NETs were visualized, quantified, and morphologically characterized by fluorescence microscopy following staining with Hoechst 33342 and Sytox Green. Levels of extracellular, cell-free neutrophil elastase (NE), myeloperoxidase (MPO), and DNA were also measured as indicators of NET release. The ability of TACT507, a proprietary RIPK3 antagonist, to efficiently block NETs formation and NET related necroptosis was evaluated. TACT507 demonstrated concentration dependent, significant inhibition of neutrophil necroptosis and NETs formation.

Preprint server: bioRxiv
The authors list and abstract were imported from bioRxiv on 22 Jul 2026.

Stats

1-terrible, 9-excellent. How would you rate this preprint? Sign in in to submit your rating.

Post a comment

You need to be signed in to post comments. You can sign in here.

Comments

There are no comments yet.